Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-13.21	23.18	26.71
Graham Fair Price	91.48	1.21	0.63
PEG	-91.71	0.05	-0.66
Price/Book	-7.57	2.33	2.52
Price/Cash Flow	40.09	-16.23	-27.10
Prices/Earnings	-72.26	13.61	49.05
Price/Sales	-16.56	2.37	2.85
Price/FCF	40.09	-16.23	-27.10
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-67.73	0.01	-0.05
Operating Margin	73.06	0.10	0.06
ROA	218.34	< 0.005	< 0.005
ROE	0.01	0.04	233.17
ROIC	0.02	0.02	21.01
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.17	< 0.005	130678.22
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	-0.52	1.01	95.74
EPS QOQ	-0.74	2.49	234.66
FCF QOQ	-1.94	-0.62	68.13
Revenue QOQ	-0.19	0.16	-14.26
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	76.68	86.26	12.49
Days Sales Outstanding (DSO)	40.22	43.62	8.45
Inventory Turnover	1.17	1.04	-11.10
Debt/Capitalization	0.59	0.62	4.62
Quick Ratio	0.39	0.44	12.13
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.17	1.23	4.90
Cash	0.53	0.65	23.02
Capex	-0.17	-0.11	34.29
Free Cash Flow	-0.11	-0.18	-61.84
Revenue	1.04	1.21	16.21
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.76	0.86	13.46
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.90	9.68	22.58
Naive Interpretation	Member

06 - Financial Health · Bad

Rating